Abstract:Active targeting drug delivery systems(TDDS),which could improve drug therapeutic efficacy and reduce toxicity,are still the focus of many scientific researches in cancer therapy.The drug circulation time and tumor accumulation could be significantly increased with the application of sterically stabilized liposome(SSL).SSL could also be modified easily with certain ligands to achieve targeting drug delivery.Because many tumors overexpress somatostatin receptors(SSTRs),octreotide(OCT)becomes a potential targeting ligand due to its high affinity to SSTRs,especially to subtype 2(SSTR2).In this study,OCT was conjugated to methoxypolyethyleneglycol-distearoyl-phosphatidylethanolamine(DSPE-PEG2000),and doxorubicin(DOX)-loaded SSL with a variable percentage of octreotide-methoxypolyethyleneglycol-distearoyl-phosphatidylethanolamine(DSPE-PEG2000-OCT)were prepared(OCT-SSL-DOX).All liposomes were about 90 nm in diameter and negatively charged on the surface,with DOX encapsulation efficiency at above 95%.OCT modification exhibited little effect on the physicochemical properties of SSL.In this study,cellular delivery efficacy of all prepared iiposomes was evaluated in SSTR2-positive cells in vitro by flow cytometry for the optimization of the OCT density on the surface of liposomes.Lipid formulation containing 1.5% DSPE-PEG2000-OCT exhibited the highest efficiency of intracellular drug delivery.The modification of OCT did not alter the release behaviors of liposomal DOX in vitro,but OCT-SSL-DOX increased the cytotoxicity and improved the anti-tumor effect of liposomal DOX in SSTR2-positive cells and tumor-bearing mice models.In summary,OCT-modified SSL succeeded in increasing intracellular delivery and enhancing therapeutic efficacy of encapsulated anticancer agent,suggesting that it might be a promising TDDS for the treatment of SSTR2-overexpressing cancers.

Octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles as potential carriers for targeted antitumor drug delivery.

In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery.

Octreotide-mediated N-octyl-O,N-carboxymethyl Chitosan Micelles:Preparation,characterization and Research As Doxorubicin Delivery Vectors

Synergistic Effects of Antitumor Efficacy Via Mixed Nano-Size Micelles of Multifunctional Bletilla Striata Polysaccharide-Based Copolymer and D-α-tocopheryl Polyethylene Glycol Succinate.

Octreotide-Modified and Ph-Triggering Polymeric Micelles Loaded with Doxorubicin for Tumor Targeting Delivery

Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.

Bio-responsive Bletilla Striata Polysaccharide-Based Micelles for Enhancing Intracellular Docetaxel Delivery

Octreotide-Modified Polymeric Micelles As Potential Carriers for Targeted Docetaxel Delivery to Somatostatin Receptor Overexpressing Tumor Cells

Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.

Octreotide-mediated Tumor Cell Uptake and Intracellular Ph-Responsive Drug Delivery of the Self-Assembly Supramolecular Nanocarrier

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Octreotide Modified PEGylated Liposomes Improved the Anticancer Efficacy of Doxorubicin in Somatostatin Receptor II Positive Tumor Model

A Novel Octreotide Modified Lipid Vesicle Improved the Anticancer Efficacy of Doxorubicin in Somatostatin Receptor 2 Positive Tumor Models

In Vitro Evaluation on Novel Modified Chitosan for Targeted Antitumor Drug Delivery.

Effect of Octreotide Surface Density on Receptor-Mediated Endocytosis in Vitro and Anticancer Efficacy of Modified Nanocarrier in Vivo after Optimization

Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.

Comparison of Active and Passive Targeting of Doxorubicin for Somatostatin Receptor 2 Positive Tumor Models by Octreotide-Modified HPMA Copolymer-Doxorubicin Conjugates.

Synthesis of Biocompatible Cholesteryl-Carboxymethyl Xylan Micelles for Tumor-Targeting Intracellular DOX Delivery.

Synthesis and Antitumor Activity of Doxorubicin Conjugated Stearic Acid-G-chitosan Oligosaccharide Polymeric Micelles

Innovative gelatin-based micelles with AS1411 aptamer targeting and reduction responsiveness for doxorubicin delivery in tumor therapy

Peptide-modified Bioresponsive Chondroitin Sulfate Micelles for Targeted Doxorubicin Delivery in Triple-Negative Breast Cancer